Varicose Vein Treatment Devices Sales

Varicose Vein Treatment Devices Sales Market Outlook

The global Varicose Vein Treatment Devices market is projected to reach approximately USD 3.5 billion by 2035, expanding at a compound annual growth rate (CAGR) of about 6.8% during the forecast period from 2025 to 2035. The growing prevalence of varicose veins, driven by factors such as an aging population, sedentary lifestyles, and increasing obesity rates, is a significant growth factor for this market. Additionally, advancements in medical technologies and treatment techniques are expected to further enhance the effectiveness and safety of varicose vein treatments, making them more appealing to patients and healthcare providers alike. The rise in awareness and acceptance of minimally invasive procedures among patients is also propelling the demand for varicose vein treatment devices. Furthermore, the expansion of healthcare infrastructure in developing regions is likely to create new opportunities for market growth as access to treatment becomes more widely available.

Growth Factor of the Market

The Varicose Vein Treatment Devices market is primarily driven by the increasing global prevalence of venous disorders, particularly among the aging population, which has led to a surge in the demand for effective treatment options. As more individuals seek medical intervention due to the discomfort and health risks associated with varicose veins, healthcare providers are increasingly investing in advanced treatment devices that assure better outcomes with minimal recovery time. Additionally, technological advancements in treatment methods, such as laser and radiofrequency ablation, are enhancing the precision and efficiency of procedures, making them more appealing to patients. Increased awareness regarding the availability of various treatment options, supported by educational campaigns from healthcare professionals, is enabling patients to make informed decisions about their treatment. Moreover, the rise of outpatient surgical centers has facilitated easier access to varicose vein treatments, further contributing to market growth.

Key Highlights of the Market

• The global market is expected to reach USD 3.5 billion by 2035.
• Minimally invasive procedures are becoming increasingly popular among patients.
• Technological innovation is significantly improving treatment efficacy and safety.
• Rising awareness and education around varicose vein treatments are driving demand.
• Expanding healthcare infrastructure, especially in emerging markets, presents new growth opportunities.

By Product Type

Laser Ablation Devices:

Laser ablation devices are becoming a preferred choice among patients and healthcare practitioners due to their minimally invasive nature and effectiveness in treating varicose veins. These devices use laser energy to target and collapse the affected veins, promoting faster recovery and less postoperative discomfort. The technology is continuously evolving, with improvements in laser wavelengths and delivery techniques enhancing treatment precision. As more clinical studies demonstrate the long-term success of laser treatment, patient acceptance is increasing, driving the demand for these devices significantly in the global market. Additionally, the convenience of outpatient procedures associated with laser treatment has made it an attractive option for both patients and providers, further boosting its market share.

Radiofrequency Ablation Devices:

Radiofrequency ablation (RFA) devices utilize thermal energy to treat varicose veins effectively, resulting in the closure of problematic veins. This method is gaining traction because of its minimally invasive characteristics, as well as the reduced risk of complications compared to traditional surgical procedures. RFA devices are noted for their ability to provide immediate results with minimal discomfort, allowing patients to return to their daily routines quickly. The technology behind RFA devices is advancing, with innovations that enhance the consistency of energy delivery and reduce recovery times, making it an appealing option for both patients and healthcare providers. The growing number of clinical studies supporting RFA as a safe and effective treatment option is also facilitating greater adoption in the market.

Sclerotherapy Devices:

Sclerotherapy is a popular treatment option for varicose veins, utilizing a solution injected into the affected veins to cause them to seal and fade away over time. Sclerotherapy devices are gaining popularity due to their simplicity and effectiveness, making them highly sought after in clinical settings. The procedure typically requires minimal recovery time, and patients are often able to resume normal activities shortly after treatment. The continued advancements in sclerotherapy solutions and delivery techniques are likely to improve treatment outcomes, driving market growth. Additionally, sclerotherapy is often seen as a cost-effective treatment option, which can be particularly attractive in markets with budget-sensitive healthcare environments.

Mechanical Compression Devices:

Mechanical compression devices are integral to the management and treatment of varicose veins, particularly for patients who may not be suitable candidates for other invasive procedures. These devices work by applying controlled pressure to the limbs, improving blood flow and reducing symptoms associated with chronic venous insufficiency. The growing awareness of the importance of compression therapy in preventing and managing varicose veins is propelling demand for these devices in the market. Furthermore, technological innovations, such as adjustable compression levels and enhanced comfort features, are attracting more patients and healthcare providers to opt for mechanical compression devices as a viable treatment option. The potential for these devices to be used in combination with other treatments also enhances their market appeal.

Others:

Other varicose vein treatment devices include a range of emerging technologies and methodologies that are gaining traction in the market. This segment encompasses various novel treatments that are being developed and tested for their efficacy and safety in managing varicose veins. Innovations such as ultrasound-guided foam sclerotherapy and newer minimally invasive techniques are attracting attention and investment from healthcare providers looking for more effective solutions. As research into alternative treatment options continues to grow, this segment is expected to expand, offering patients a broader array of choices when it comes to managing their varicose veins. The diversity of options available may lead to increased patient satisfaction and improved overall outcomes, ultimately driving market growth.

By Application

Hospitals:

Hospitals play a pivotal role in the delivery of varicose vein treatment services, often being the primary care setting for patients seeking intervention. The advanced facilities and comprehensive patient care available in hospitals contribute to the increasing demand for varicose vein treatment devices. Hospitals are equipped with state-of-the-art technologies that enable the adoption of the latest treatment methodologies, including laser and radiofrequency ablation. Additionally, the presence of specialized vascular surgeons in hospitals enhances treatment effectiveness and patient outcomes. As the prevalence of varicose veins continues to rise, hospitals are expected to witness significant growth in the demand for treatment devices as more patients seek surgical and non-surgical options for managing their condition.

Specialty Clinics:

Specialty clinics focusing on vein treatment are becoming increasingly popular for patients seeking targeted and specialized care for varicose veins. These clinics often offer a comprehensive range of treatment options, from minimally invasive procedures to conservative management strategies, thus attracting patients looking for effective solutions. The patient-centric approach and personalized care provided in specialty clinics contribute to higher patient satisfaction and positive treatment outcomes. Additionally, the growing trend of outpatient procedures means that many patients prefer specialty clinics due to convenience and reduced wait times. As specialty clinics continue to enhance their offerings and invest in advanced technologies, this segment is expected to play a significant role in the overall varicose vein treatment devices market.

Ambulatory Surgical Centers:

Ambulatory surgical centers (ASCs) are redefining the landscape of varicose vein treatment by providing patients with quick, efficient, and cost-effective options for managing their conditions. ASCs are designed to offer same-day surgical services, allowing patients to undergo treatment and return home within hours, thereby eliminating the need for overnight hospitalization. This convenience is driving the adoption of varicose vein treatment devices in ASCs, as patients increasingly seek out less disruptive treatment options that fit their lifestyles. Furthermore, the emphasis on patient comfort and satisfaction in ASCs enhances their attractiveness, leading to an expanding share of the overall market. As healthcare systems move towards outpatient services, ASCs are uniquely positioned to capture a larger segment of the varicose vein treatment market.

Others:

This category encompasses a variety of additional settings where varicose vein treatment devices are utilized, including community health centers and home care services. These alternative care settings are gaining traction as patients seek more accessible and affordable treatment options. The increasing prevalence of telemedicine is facilitating consultations and follow-ups, allowing patients to receive care from the comfort of their homes. This trend is particularly beneficial for patients in rural or underserved areas who may not have easy access to specialized healthcare facilities. The development of home-based treatment options and the growing acceptance of telehealth solutions are likely to expand this segment, providing more opportunities for varicose vein treatment devices in diverse settings.

By User

Hospitals:

Hospitals serve as a primary user of varicose vein treatment devices, leveraging advanced technologies and specialized staff to provide comprehensive care for patients with venous disorders. The diverse array of treatment options available within hospitals ensures that patients have access to the latest advancements in technology and care practices. Hospitals often conduct a higher volume of procedures, which fosters a steady demand for treatment devices. As the number of patients seeking varicose vein treatments continues to rise, hospitals are likely to invest in new devices and technologies to enhance their treatment capabilities and maintain competitive advantage in the healthcare landscape.

Clinics:

Clinics represent a significant user segment for varicose vein treatment devices, particularly those that specialize in vascular health. These clinics often focus on providing personalized care and tailored treatment plans that meet the specific needs of their patients. The increasing prevalence of varicose veins has driven clinics to expand their treatment offerings and invest in innovative devices that improve patient outcomes. The demand for minimally invasive procedures is particularly evident in this setting, prompting clinics to adopt advanced technologies that align with patient preferences. As clinics enhance their capabilities and expand their service offerings, they will continue to play a crucial role in driving the growth of the varicose vein treatment devices market.

Ambulatory Surgical Centers:

Ambulatory Surgical Centers (ASCs) are emerging as key users of varicose vein treatment devices, capitalizing on the trend of outpatient surgical procedures. These centers are designed to provide patients with a streamlined and efficient surgical experience, allowing for same-day procedures that minimize disruption to their lives. The demand for varicose vein treatments in ASCs is fueled by the growing preference for less invasive techniques and faster recovery times. As ASCs continue to provide high-quality care and expand their procedural capabilities, they will increasingly rely on advanced treatment devices to meet the needs of their patients. This trend is expected to drive significant growth in the ASC segment of the market.

Others:

This segment includes non-traditional users of varicose vein treatment devices, such as community health centers and telemedicine platforms that provide remote consultations and follow-up care. The rise of telehealth has enabled patients to access expert guidance without the need for in-person visits, leading to a shift in how care is delivered. As more patients become aware of the treatment options available for varicose veins, demand for devices in these alternative settings is expected to increase. Additionally, the focus on cost-effective treatment options in community health centers is likely to drive the adoption of varicose vein treatment devices, as patients seek accessible care solutions that fit within their budgets. The evolution of care delivery models will continue to shape the landscape of varicose vein treatment devices in the coming years.

By Technology

Endovenous Ablation:

Endovenous ablation has become a cornerstone technology for treating varicose veins, utilizing thermal energy to target and close off problematic veins. This technique is often favored for its minimally invasive approach, which typically results in reduced recovery times and better patient outcomes compared to traditional surgical methods. As the demand for outpatient treatments grows, endovenous ablation technologies are seeing increased adoption among healthcare providers, who appreciate the efficiency and effectiveness of this method. Ongoing advancements in catheter design and energy delivery systems continue to improve the precision and safety of endovenous ablation, further solidifying its role in the varicose vein treatment devices market.

Sclerotherapy:

Sclerotherapy remains a widely-used technology for managing varicose veins, as it involves injecting a sclerosing solution into the affected veins to cause them to collapse and eventually fade away. This non-invasive treatment method appeals to patients due to its simplicity and effectiveness, resulting in minimal downtime and discomfort. Innovations in sclerotherapy solutions, including the development of ultrasound-guided techniques, are enhancing the precision and effectiveness of the treatment. As awareness of this technology grows and providers invest in training on the latest techniques, the adoption of sclerotherapy devices is expected to increase, contributing to the overall growth of the varicose vein treatment market.

Laser Treatment:

Laser treatment has emerged as a revolutionary technology in the management of varicose veins, offering a targeted approach to closing affected veins with minimal invasiveness. By using focused laser energy, this method effectively seals off veins without the need for incisions, resulting in reduced scarring and quicker recovery times. As advancements in laser technology continue to evolve, such as the introduction of different wavelengths and laser delivery systems, the effectiveness of laser treatments is expected to improve further. Patients and healthcare providers alike are increasingly recognizing the benefits of laser treatment, leading to a growing market presence for laser treatment devices in the varicose vein treatment landscape.

Others:

The 'Others' category in technology encompasses emerging and experimental treatments that are gaining attention in the varicose vein management space. This includes innovative techniques such as ultrasound-guided foam sclerotherapy and newer forms of mechanical compression therapy that aim to enhance patient outcomes. Research and development are ongoing, with healthcare providers exploring various technologies to provide more effective management solutions for varicose veins. As these technologies undergo clinical trials and receive regulatory approval, they have the potential to diversify the treatment options available in the market and further drive growth in the varicose vein treatment devices market.

By Region

The North American varicose vein treatment devices market is expected to dominate the global landscape, accounting for a significant share due to the high prevalence of venous disorders, advanced healthcare infrastructure, and a strong emphasis on minimally invasive treatment options. The market in this region is projected to grow at a CAGR of approximately 7.5% during the forecast period, driven by increasing awareness of available treatment options and the growing population of aging individuals susceptible to varicose veins. Moreover, the presence of key market players and continuous innovation in treatment technologies are likely to further propel the growth of this market segment.

Europe is also a major contributor to the global varicose vein treatment devices market, characterized by a substantial share due to increasing healthcare expenditure and a well-established healthcare system. The growing demand for aesthetic procedures among the European population is further fueling the need for effective varicose vein treatments. Emerging markets within Europe, particularly in Eastern Europe, are expected to witness significant growth as access to advanced medical technologies improves. The market dynamics in this region align closely with the global trends, ensuring that Europe remains a critical player in the varicose vein treatment devices market.

Opportunities

The Varicose Vein Treatment Devices market presents numerous opportunities for growth, particularly in emerging economies where healthcare infrastructure is rapidly expanding. As these regions experience an upsurge in the prevalence of venous disorders, the need for effective treatment solutions is becoming increasingly important. Investment in medical facilities and the availability of advanced treatment technologies are likely to facilitate improved access to varicose vein treatments for a larger segment of the population. Additionally, the rising disposable income and increasing healthcare spending in these regions will contribute to the demand for advanced treatment devices, allowing for the introduction of innovative solutions tailored to local market needs. This growth potential offers significant opportunities for companies looking to penetrate these emerging markets and establish a foothold in the varicose vein treatment landscape.

Furthermore, advancements in telemedicine and remote patient monitoring are opening new avenues for varicose vein treatment delivery. The ability to provide consultations and follow-ups via telehealth platforms allows healthcare providers to reach a broader audience, particularly those in rural or underserved areas. As telehealth becomes an integral part of the healthcare delivery system, the demand for varicose vein treatment devices is expected to grow, driven by patients seeking accessible and convenient care options. This trend towards digital health solutions is likely to encourage innovation in treatment technologies, fostering the development of devices that are compatible with telehealth services, thus creating additional opportunities for market players.

Threats

Despite the promising growth prospects of the Varicose Vein Treatment Devices market, various threats could potentially hinder its progress. One of the primary concerns is the increasing competition among manufacturers, leading to price wars that could affect profit margins. As more players enter the market and introduce cost-effective devices, established companies may face pressure to lower their prices, which can impact their revenue and operational sustainability. Moreover, the rapid pace of technological advancement necessitates continuous investment in research and development, which can be a significant financial burden for companies, especially smaller players. The regulatory landscape surrounding medical devices is also becoming more stringent, which may pose challenges in terms of compliance and approval processes, thereby delaying product launches and affecting market dynamics.

Another major threat is the potential for negative patient outcomes associated with certain treatments, which could lead to increased scrutiny and a decline in patient trust. Adverse effects or complications from varicose vein treatments could deter patients from seeking care, ultimately impacting device adoption rates. Furthermore, the growing popularity of alternative treatment options, such as lifestyle changes and natural remedies, may shift patient preferences away from conventional medical intervention, posing a challenge for the industry. Addressing these threats will require innovative approaches to device development, effective marketing strategies, and a commitment to ensuring patient safety and satisfaction in the evolving healthcare landscape.

Competitor Outlook

• Medtronic plc
• Boston Scientific Corporation
• Abbott Laboratories
• AngioDynamics, Inc.
• Veniti, Inc.
• Cordis, a Cardinal Health Company
• Quanta Dialysis Technologies Ltd.
• SentreHEART, Inc.
• Biolase, Inc.
• BD (Becton, Dickinson and Company)
• Merit Medical Systems, Inc.
• Sciton, Inc.
• Inari Medical, Inc.
• Vascular Insights, LLC
• Halyard Health, Inc.

The competitive landscape of the Varicose Vein Treatment Devices market is characterized by a dynamic mix of established players and emerging companies striving for market share. Major companies, such as Medtronic, Boston Scientific, and Abbott Laboratories, hold significant portions of the market due to their extensive product offerings, established brand reputations, and robust distribution networks. These companies continuously invest in research and development to innovate and enhance the efficacy of their devices, ensuring that they remain at the forefront of the market. Their ability to leverage advanced technologies and clinical evidence to support their product claims further enhances their competitive edge in the varicose vein treatment landscape.

Emerging companies, such as Veniti and Inari Medical, are also making strides in the varicose vein treatment devices market by introducing novel technologies and approaches. These companies often focus on niche markets and specialized devices that cater to specific patient needs, allowing them to differentiate themselves from larger competitors. Their agility and innovation are driving advancements in the industry, fostering a competitive environment that encourages continuous improvement and evolution of treatment options. As these emerging players gain traction, they are likely to challenge established companies and reshape the market dynamics in the coming years.

In addition to product innovation, strategic collaborations, mergers, and acquisitions are common strategies employed by companies in the Varicose Vein Treatment Devices market. By forming partnerships with research institutions, healthcare providers, and technology firms, established players can expand their product portfolios and access new markets. Acquisitions of smaller companies with innovative technologies can provide established firms with a competitive advantage, enabling them to integrate cutting-edge solutions into their offerings. This proactive approach to competition is crucial for companies looking to enhance their market presence and respond effectively to the evolving needs of patients and healthcare providers.

• 1 Appendix

  • 1.1 List of Tables
  • 1.2 List of Figures

• 2 Introduction

  • 2.1 Market Definition
  • 2.2 Scope of the Report
  • 2.3 Study Assumptions
  • 2.4 Base Currency & Forecast Periods

• 3 Market Dynamics

  • 3.1 Market Growth Factors
  • 3.2 Economic & Global Events
  • 3.3 Innovation Trends
  • 3.4 Supply Chain Analysis

• 4 Consumer Behavior

  • 4.1 Market Trends
  • 4.2 Pricing Analysis
  • 4.3 Buyer Insights

• 5 Key Player Profiles

  • 5.1 Sciton, Inc.
    • 5.1.1 Business Overview
    • 5.1.2 Products & Services
    • 5.1.3 Financials
    • 5.1.4 Recent Developments
    • 5.1.5 SWOT Analysis
  • 5.2 Veniti, Inc.
    • 5.2.1 Business Overview
    • 5.2.2 Products & Services
    • 5.2.3 Financials
    • 5.2.4 Recent Developments
    • 5.2.5 SWOT Analysis
  • 5.3 Biolase, Inc.
    • 5.3.1 Business Overview
    • 5.3.2 Products & Services
    • 5.3.3 Financials
    • 5.3.4 Recent Developments
    • 5.3.5 SWOT Analysis
  • 5.4 Medtronic plc
    • 5.4.1 Business Overview
    • 5.4.2 Products & Services
    • 5.4.3 Financials
    • 5.4.4 Recent Developments
    • 5.4.5 SWOT Analysis
  • 5.5 SentreHEART, Inc.
    • 5.5.1 Business Overview
    • 5.5.2 Products & Services
    • 5.5.3 Financials
    • 5.5.4 Recent Developments
    • 5.5.5 SWOT Analysis
  • 5.6 Abbott Laboratories
    • 5.6.1 Business Overview
    • 5.6.2 Products & Services
    • 5.6.3 Financials
    • 5.6.4 Recent Developments
    • 5.6.5 SWOT Analysis
  • 5.7 AngioDynamics, Inc.
    • 5.7.1 Business Overview
    • 5.7.2 Products & Services
    • 5.7.3 Financials
    • 5.7.4 Recent Developments
    • 5.7.5 SWOT Analysis
  • 5.8 Inari Medical, Inc.
    • 5.8.1 Business Overview
    • 5.8.2 Products & Services
    • 5.8.3 Financials
    • 5.8.4 Recent Developments
    • 5.8.5 SWOT Analysis
  • 5.9 Halyard Health, Inc.
    • 5.9.1 Business Overview
    • 5.9.2 Products & Services
    • 5.9.3 Financials
    • 5.9.4 Recent Developments
    • 5.9.5 SWOT Analysis
  • 5.10 Vascular Insights, LLC
    • 5.10.1 Business Overview
    • 5.10.2 Products & Services
    • 5.10.3 Financials
    • 5.10.4 Recent Developments
    • 5.10.5 SWOT Analysis
  • 5.11 Merit Medical Systems, Inc.
    • 5.11.1 Business Overview
    • 5.11.2 Products & Services
    • 5.11.3 Financials
    • 5.11.4 Recent Developments
    • 5.11.5 SWOT Analysis
  • 5.12 Boston Scientific Corporation
    • 5.12.1 Business Overview
    • 5.12.2 Products & Services
    • 5.12.3 Financials
    • 5.12.4 Recent Developments
    • 5.12.5 SWOT Analysis
  • 5.13 Cordis, a Cardinal Health Company
    • 5.13.1 Business Overview
    • 5.13.2 Products & Services
    • 5.13.3 Financials
    • 5.13.4 Recent Developments
    • 5.13.5 SWOT Analysis
  • 5.14 Quanta Dialysis Technologies Ltd.
    • 5.14.1 Business Overview
    • 5.14.2 Products & Services
    • 5.14.3 Financials
    • 5.14.4 Recent Developments
    • 5.14.5 SWOT Analysis
  • 5.15 BD (Becton, Dickinson and Company)
    • 5.15.1 Business Overview
    • 5.15.2 Products & Services
    • 5.15.3 Financials
    • 5.15.4 Recent Developments
    • 5.15.5 SWOT Analysis

• 6 Market Segmentation

  • 6.1 Varicose Vein Treatment Devices Sales Market, By User
    • 6.1.1 Hospitals
    • 6.1.2 Clinics
    • 6.1.3 Ambulatory Surgical Centers
    • 6.1.4 Others
  • 6.2 Varicose Vein Treatment Devices Sales Market, By Technology
    • 6.2.1 Endovenous Ablation
    • 6.2.2 Sclerotherapy
    • 6.2.3 Laser Treatment
    • 6.2.4 Others
  • 6.3 Varicose Vein Treatment Devices Sales Market, By Application
    • 6.3.1 Hospitals
    • 6.3.2 Specialty Clinics
    • 6.3.3 Ambulatory Surgical Centers
    • 6.3.4 Others
  • 6.4 Varicose Vein Treatment Devices Sales Market, By Product Type
    • 6.4.1 Laser Ablation Devices
    • 6.4.2 Radiofrequency Ablation Devices
    • 6.4.3 Sclerotherapy Devices
    • 6.4.4 Mechanical Compression Devices
    • 6.4.5 Others

• 7 Competitive Analysis

  • 7.1 Key Player Comparison
  • 7.2 Market Share Analysis
  • 7.3 Investment Trends
  • 7.4 SWOT Analysis

• 8 Research Methodology

  • 8.1 Analysis Design
  • 8.2 Research Phases
  • 8.3 Study Timeline

• 9 Future Market Outlook

  • 9.1 Growth Forecast
  • 9.2 Market Evolution

• 10 Geographical Overview

  • 10.1 Europe - Market Analysis
    • 10.1.1 By Country
      • 10.1.1.1 UK
      • 10.1.1.2 France
      • 10.1.1.3 Germany
      • 10.1.1.4 Spain
      • 10.1.1.5 Italy
  • 10.2 Asia Pacific - Market Analysis
    • 10.2.1 By Country
      • 10.2.1.1 India
      • 10.2.1.2 China
      • 10.2.1.3 Japan
      • 10.2.1.4 South Korea
  • 10.3 Latin America - Market Analysis
    • 10.3.1 By Country
      • 10.3.1.1 Brazil
      • 10.3.1.2 Argentina
      • 10.3.1.3 Mexico
  • 10.4 North America - Market Analysis
    • 10.4.1 By Country
      • 10.4.1.1 USA
      • 10.4.1.2 Canada
  • 10.5 Middle East & Africa - Market Analysis
    • 10.5.1 By Country
      • 10.5.1.1 Middle East
      • 10.5.1.2 Africa
  • 10.6 Varicose Vein Treatment Devices Sales Market by Region

• 11 Global Economic Factors

  • 11.1 Inflation Impact
  • 11.2 Trade Policies

• 12 Technology & Innovation

  • 12.1 Emerging Technologies
  • 12.2 AI & Digital Trends
  • 12.3 Patent Research

• 13 Investment & Market Growth

  • 13.1 Funding Trends
  • 13.2 Future Market Projections

• 14 Market Overview & Key Insights

  • 14.1 Executive Summary
  • 14.2 Key Trends
  • 14.3 Market Challenges
  • 14.4 Regulatory Landscape

Segments Analyzed in the Report

The global Varicose Vein Treatment Devices Sales market is categorized based on

By Product Type

• Laser Ablation Devices
• Radiofrequency Ablation Devices
• Sclerotherapy Devices
• Mechanical Compression Devices
• Others

By Application

• Hospitals
• Specialty Clinics
• Ambulatory Surgical Centers
• Others

By User

• Hospitals
• Clinics
• Ambulatory Surgical Centers
• Others

By Technology

• Endovenous Ablation
• Sclerotherapy
• Laser Treatment
• Others

By Region

• North America
• Europe
• Asia Pacific
• Latin America
• Middle East & Africa

Key Players

• Medtronic plc
• Boston Scientific Corporation
• Abbott Laboratories
• AngioDynamics, Inc.
• Veniti, Inc.
• Cordis, a Cardinal Health Company
• Quanta Dialysis Technologies Ltd.
• SentreHEART, Inc.
• Biolase, Inc.
• BD (Becton, Dickinson and Company)
• Merit Medical Systems, Inc.
• Sciton, Inc.
• Inari Medical, Inc.
• Vascular Insights, LLC
• Halyard Health, Inc.